Capstone Investments Starts Sagent Pharmaceuticals (SGNT) at Buy
Tweet
Share
E-mailGet Alerts SGNT Hot Sheet
Price: $21.76 --0%
Rating Summary:
1 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 18 | New: 28
Rating Summary:
1 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 18 | New: 28
Join SI Premium – FREE
Capstone Investments initiates coverage on Sagent Pharmaceuticals (NASDAQ: SGNT) with a Buy. PT $27.00.
For an analyst ratings summary and ratings history on Sagent Pharmaceuticals click here. For more ratings news on Sagent Pharmaceuticals click here.
Shares of Sagent Pharmaceuticals closed at $21.50 yesterday.
For an analyst ratings summary and ratings history on Sagent Pharmaceuticals click here. For more ratings news on Sagent Pharmaceuticals click here.
Shares of Sagent Pharmaceuticals closed at $21.50 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Starts Capital Bancorp (CBNK) at Market Perform
- StoneX Starts Monolithic Power Systems (MPWR) at Buy, 'Lean, Green, Monolithic Machine'
- Morgan Stanley Resumes Partners Group Holding AG (PGHN:SW) (PGPHF) at Equalweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
Capstone InvestmentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
